Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)

Shanghai No.1 Pharmacy Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	420.94	436.42	400.03	504.93	262.28	509.43
Short-Term Investments	106.82	85.62	66.29	40	-	-
Trading Asset Securities	35.08	15.38	30.15	220.29	-	-
Cash & Short-Term Investments	562.83	537.41	496.47	765.22	262.28	509.43
Cash Growth	20.87%	8.25%	-35.12%	191.75%	-48.51%	7.54%
Accounts Receivable	175.79	190.15	247.57	238	133.56	130.82
Other Receivables	40.77	30.4	23.31	27.1	31.32	10.07
Receivables	216.56	220.55	270.88	265.1	164.87	140.89
Inventory	382.14	336.32	332.23	334.75	214.5	215.58
Prepaid Expenses	-	9.39	3.52	0.78	0.44	0.15
Other Current Assets	39.66	23.33	14.13	31.29	20.59	13.3
Total Current Assets	1,201	1,127	1,117	1,397	662.69	879.35
Property, Plant & Equipment	249.43	260.88	215.36	181.09	167.98	72.47
Long-Term Investments	289.17	342.74	322.45	252.47	184.14	180.14
Other Intangible Assets	38.23	38.93	41.67	43.83	46.33	48.19
Long-Term Deferred Tax Assets	27.03	24.35	26.39	35.99	12.07	7.19
Long-Term Deferred Charges	20.28	20.58	16.28	14.43	9.28	8.91
Other Long-Term Assets	162.39	165.58	123.78	114.15	251.97	200
Total Assets	1,988	1,980	1,863	2,039	1,334	1,396
Accounts Payable	448.93	384.14	398.59	363.69	314.8	291.97
Accrued Expenses	2.69	27.14	27.09	32.57	15.02	35.93
Short-Term Debt	59.96	95.58	101.05	320.28	-	180.11
Current Portion of Leases	63.37	63.98	58.34	49.05	38.94	-
Current Income Taxes Payable	10.13	0.9	10.27	37.33	5.93	3.6
Current Unearned Revenue	6.36	5.36	5.71	25.53	2.71	4.31
Other Current Liabilities	71.79	71.05	75.74	97.91	66.64	81.41
Total Current Liabilities	663.23	648.15	676.79	926.37	444.04	597.33
Long-Term Leases	104.3	115.56	107.24	88.33	63.08	-
Long-Term Unearned Revenue	11.85	11.97	12.44	11.3	11.68	12.4
Long-Term Deferred Tax Liabilities	57.22	57.48	55.83	54.34	37.34	36.46
Other Long-Term Liabilities	-	-	-	0.07	0.4	0.75
Total Liabilities	838.99	835.66	854.72	1,080	556.54	646.94
Common Stock	223.09	223.09	223.09	223.09	223.09	223.09
Additional Paid-In Capital	65.53	65.53	65.19	65.19	65.19	65.19
Retained Earnings	684.72	679.98	544.95	499.18	371.24	345.01
Comprehensive Income & Other	166.55	167.01	168.22	164.22	111.4	109.03
Total Common Equity	1,140	1,136	1,001	951.67	770.92	742.31
Minority Interest	8.85	8.79	7.01	7.01	7.01	7.01
Shareholders' Equity	1,149	1,144	1,008	958.68	777.92	749.32
Total Liabilities & Equity	1,988	1,980	1,863	2,039	1,334	1,396
Total Debt	227.63	275.12	266.63	457.67	102.03	180.11
Net Cash (Debt)	335.21	262.29	229.83	307.55	160.26	329.32
Net Cash Growth	76.97%	14.12%	-25.27%	91.91%	-51.34%	-30.48%
Net Cash Per Share	1.50	1.17	1.03	1.37	0.71	1.49
Filing Date Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Total Common Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Working Capital	537.97	478.85	440.44	470.77	218.65	282.02
Book Value Per Share	5.11	5.09	4.49	4.27	3.46	3.33
Tangible Book Value	1,102	1,097	959.77	907.85	724.58	694.12
Tangible Book Value Per Share	4.94	4.92	4.30	4.07	3.25	3.11
Buildings	-	105.19	89.34	94.76	94.76	95.56
Machinery	-	26.96	26.52	26	26.32	33.11
Construction In Progress	-	5.74	1.74	1.43	2.24	1.14

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.